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Introduction
The genus Cyclopia (family: Fabaceae), comprising c. 24
species, is part of the rich fynbos plant kingdom of the Western
Cape province of South Africa.1 Cyclopia intermedia, C. subternata,
C. genistoides and, to a lesser extent, C. sessiliflora, are species that
are processed commercially. Cyclopia, commonly known as
honeybush tea owing to its sweet distinct aroma and flavour, is
growing in popularity. Traditionally, only ‘fermented’ honey-
bush tea was available to the public, but the ‘unfermented’
(green) tea has recently been introduced to local and interna-
tional markets. The fermentation (oxidation) step during
processing, which is necessary to release the characteristic
sensory properties, reduces the total phenolic content of the
plant material.2 Several studies that investigated the chemical
composition of Cyclopia reported that mangiferin and hesperi-
din are the main compounds present.3–6 Ferreira et al.4 studied
the phenolic composition of fermented C. intermedia and found,
amongst others, formononetin, mangiferin, naringenin,
eriodictyol, hesperetin, hesperidin, medicagol, flemichapparin,
sopharacoumestan B and luteolin. A subsequent study involv-
ing unfermented C. subternata revealed a phenolic composition
that also included luteolin, mangiferin and hesperidin, but with
the additional presence of narirutin and eriocitrin, amongst
others, which were not present in C. intermedia.5
Recently, honeybush tea has been identified as displaying
antioxidant and antimutagenic activity, which is thought to be
due to its phenolic composition.7–9 The phenols present in
Cyclopia, however, may have additional biological activities. For
example, formononetin, naringenin, eriodictyol and luteolin
are known to have weak oestrogenic effects.10–12 Phenolic plant
compounds able to mediate an oestrogenic effect are commonly
referred to as phyto-oestrogens, which are believed to alleviate
menopausal symptoms and to protect against cardiovascular
disease and osteoporosis.13–15 Plant extracts of Cimicifuga racemosa
(black cohosh)16 and Trifolium pratense (red clover)17 are available
commercially in western countries for the treatment of meno-
pausal symptoms.18
The public is more inclined towards the use of ‘natural’
products, which they believe have fewer side-effects, than
synthetic drugs.19 Their perceptions as related specifically to
phyto-oestrogens are supported by both epidemiological studies
and recent reports of health risks associated with conventional
medicine. Epidemiological studies have shown that the incidence
of breast cancer and prostate cancer is much lower in Asian than
Western populations20 and that this phenomenon is associated
with the traditional Asian diet, which contains high levels of
soya.21 The isoflavone, genistein, present in soybean, was isolated
and identified as the principal contributor to these findings.22
Two clinical trials, involving hormone replacement therapy
(HRT), by the Women’s Health Initiative, had to be prematurely
stopped due to health risks, in particular breast cancer, cardio-
vascular disease and stroke.23,24 Alternatives to traditional HRT
being investigated thus include phyto-oestrogens, believed to
minimize the risks associated with the therapy, while retaining
the health benefits and even protecting against hormone-
related cancers. Although these beliefs are supported by the
literature,25–27 some studies suggest that phyto-oestrogens may
not be effective in alleviating menopausal symptoms.28 Despite
this caveat, phyto-oestrogens are in demand by the public and
new plant sources of these compounds are investigated regularly
for exploitation by the nutraceutical industry.
Oestrogens are responsible for numerous physiological
effects, especially in reproductive tissues.29 Beneficial physiolog-
ical outcomes include maintaining or increasing bone density30
and protecting against cardiovascular disease.31 However,
because of their stimulating effect on growth and proliferation of
certain cells, they are a risk factor for breast and endometrial
cancer.32,33 Oestrogen signalling is mediated mainly via the
oestrogen receptors (ERs) to which oestrogens bind. Such bind-
ing induces a conformational change and dissociation of heat
shock proteins. This is followed by dimerization and binding to
the classic oestrogen response element, whereby it is able to
mediate a biological response.34
Two ER subtypes, namely ER-alpha (ERα)35 and ER-beta
(ERβ),36 have been identified. Both are capable of stimulating
transcription of ER target genes. The degree of oestradiol (E2)
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Phyto-oestrogens mediate an oestrogenic effect through binding to
the oestrogen receptor (ER) subtypes, ERα and ERβ. Four commer-
cially available Cyclopia (honeybush) species—C. intermedia, C.
subternata, C. genistoides and C. sessiliflora—together with nine
commercially obtainable polyphenols present in some or all of the
species, were screened for phyto-oestrogenic activity, using a
competitive whole-cell ER binding assay. Only naringenin,
formononetin and luteolin were able significantly to displace 3H-E2
from hERα, whereas luteolin, naringenin, formononetin, eriodictyol,
narirutin and eriocitrin displaced 3H-E2 from hERβ. Mangiferin,
hesperidin and hesperetin did not bind to either receptor subtype.
To our knowledge, this is the first time that binding of eriodictyol,
eriocitrin and narirutin to the hERβ has been shown. Furthermore,
both aqueous and methanol extracts from three independent
harvestings of each Cyclopia species were screened. The results
suggest that C. genistoides and C. subternata display significant
phyto-oestrogenic activity and that methanol extracts from ‘unfer-
mented’ (unoxidized) plant material generally display greater activity.
Great variation exists within a species, however, with one C. geni-
stoides harvesting displacing 3H-E2 from both ER subtypes, while
another harvesting displaced 3H-E2 from only hERβ, and a third did
not displace 3H-E2 from either receptor subtype.
activation (fold induction) through ERβ in many cell types is,
however, lower than that of ERα. Physiologically, ERβ decreases
the overall sensitivity to E2 in ERα-mediated gene transcription,
and is believed to be the natural cellular protective mechanism
against over-proliferation of cells that could lead to cancer for-
mation.37–39 Compounds that bind with a higher affinity to ERβ
than ERα are thus of great interest pharmacologically. Phyto-
oestrogens, which could be a natural alternative or supplement
for the treatment of menopausal women, have been shown
preferentially to bind to the ERβ.40–42
In the study reported here, selected commercially available
polyphenols present in Cyclopia as well as extracts of the four
most commonly available Cyclopia species, namely, C. genistoides,
C. subternata, C. sessiliflora and C. intermedia, were investigated by
evaluating their interaction with both ERα and ERβ. The poly-
phenols were screened for use as possible marker compounds of
oestrogenicity in Cyclopia, while the extracts of the Cyclopia
plants were screened to identify the species with the highest
oestrogenicity. Both aqueous extracts (as a ‘cup of tea’), from
fermented and unfermented Cyclopia plant material, and metha-
nol extracts from unfermented Cyclopia material, were tested.
We also investigated three different harvestings of each species
to eliminate false negatives and to include variations due to
growth conditions and/or genetic effects. Phenolic compounds
are especially known to occur at high concentrations in plants
that are under stress.43,44 Binding to the ER subtypes was chosen
as a screening assay, because it constitutes the first step in the
signal transduction pathway mediating an oestrogenic effect.
Materials and methods
Test compounds
Test compounds included 17-β-oestradiol, genistein, mangiferin,
hesperetin, hesperidin, and naringenin (Sigma-Aldrich) and luteolin,
formononetin, eriodictyol, narirutin, and eriocitrin (Extrasynthese,
France) (Fig. 1). Radiolabelled ligand, 2,4,6,7-[3H]17-β-oestradiol (specific
activity 87.0 Ci mmol–1, counting efficiency of 46%) was from Amersham.
Plant material
Three randomly chosen independent harvestings of C. intermedia,
C. subternata, C. genistoides and C. sessiliflora were selected. Plant material
for the aqueous extracts (Table 1) was processed according to a standard
method for fermented and unfermented tea.2 Briefly, the leaves and
stems were cut into small pieces. For the fermented extracts the shredded
plant material was moistened with deionized water to c. 60% moisture
content, after which fermentation at 70°C for 60 h, followed by drying
at 40°C for 12 h to c. 10% moisture content, took place. Unfermented
material was dried directly after shredding at 40°C for 12 h. The dried
plant material was then sieved with an Endecott test sieve (2 mm) and
the fraction smaller than 2 mm pulverized with a Retsch rotary mill
(1-mm sieve), which was stored in plastic containers at room temperature.
The plant material for the preparation of the methanol extracts (Table 2)
was dried whole at 40°C to c. 10% moisture content, after which it was
pulverized and stored in plastic containers at room temperature.
Dried aqueous extract preparation
Dried aqueous extracts (DAE) were prepared by E.S. Richards.7 Briefly,
100 g of pulverized, processed (fermented and unfermented) plant
material (Table 1) was steeped in 1 litre of freshly boiled deionized water
for 5 min while stirring. Extracts were then filtered through 125-µm
Polymon mesh cloth followed by filtration through Whatman No. 4 filter
paper. The filtrate was stored at –20°C before freeze-drying. The
freeze-dried DAE were stored at room temperature in sealed glass vials,
covered with aluminium foil, in desiccators kept in the dark.
Dried methanol extract preparation
The plant material used for dried methanol extracts (DME) of
unfermented Cyclopia material (Table 2) was not the same as that used to
prepare the DAE. Dried, pulverized unfermented plant material (25 g)
was extracted three times with 50 ml dichloromethane (UNIV AR,
Merck) at room temperature for 20 h each and the filtrate was discarded.
Thereafter, methanol extraction (50 ml) of the air-dried plant material
was performed twice at room temperature for 20 h each. The methanol
extracts were pooled with a small volume of water added and evaporated
under vacuum before freeze-drying. Freeze-dried DME were ground in
a darkened room until a fine homogeneous powder was obtained,
which was stored in screw-cap glass vials, covered with aluminium foil,
and placed in vacuum-sealed desiccators in the dark at room temperature.
Extract yield
The extract yield was determined by calculating the mass of dry extract
(DAE or DME) per 100 g of initial processed plant material.
Determination of total polyphenol content of DAE and DME
The total polyphenol (TPP) content of the DAE and DME was quanti-
fied colorimetrically in triplicate. The method of Singleton and Rossi45
was adapted for use in flat-bottomed, 96-well plates (B & M Scientific).
Briefly, 20 µl of sample [gallic acid (Sigma-Aldrich) standards
(0.01–0.1 mg ml–1), or DAE and DME (0.25 mg ml–1)] were allowed to react
with 100 µl 10% (v/v) Folin-Ciocalteau reagent (Merck) in the presence of
80 µl 7.5% (w/v) Na2CO3 at 37°C for 2 h. Absorbance was measured at
620 nm using a microtitre plate reader, recorded, and gallic acid equiva-
lents obtained from the standard curve. The TPP content was calculated
as gallic acid equivalents per 100 g of freeze-dried extract.
Binding to ER subtypes
The ability of the polyphenols and extracts to bind to the receptors was
investigated by the competitive whole-cell receptor binding assay by
transiently transfecting COS-1 cells, which do not endogenously express
ERα or ERβ,46 with either hERα or hERβ.
Cell culture conditions
COS-1 cells (ATCC) were maintained in DMEM (Sigma-Aldrich)
supplemented with 10% (v/v) FCS (Highveld Biological, Johannesburg),
and penicillin (100 IU ml–1) and streptomycin (100 µl ml–1) (penicillin–
streptomycin) from Gibco-BRL Life Technologies. COS-1 cells were
plated at a density of 2 × 106 cells per 10 cm tissue culture dish (Nunc).
Transient transfections
Twenty-four hours after plating, the COS-1 cells were transiently
transfected with expression vectors for one of the ER subtypes, pcDNA3-
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Fig. 1. Chemical structures of the polyphenols and E2 investigated in this study.
hERα (D. Harnish, Wyeth-Ayerst Research,
USA) or pSG5-hERβ (F. Gannon, European
Molecular Biology Laboratory, Germany), an
expression vector for β-galactosidase,
pCMV-βgal (Stratagene), and a filler vector,
empty pGL2-basic (Promega Corp.), using
the DEAE-Dextran transfection method47
adapted as described.
Transfections were carried out in 10 cm tis-
sue culture dishes and cells re-plated 24 h
later into 12-well plates. Briefly, 4950 µl
DMEM pre-heated to 37°C and containing
0.1 mM chloroquine (Sigma-Aldrich) (stock
solution 100 mM) and 6 µg DNA (720 ng re-
ceptor, 480 ng β-galactosidase expression vec-
tor and 4.8 µg filler vector) was prepared per
10 cm tissue culture dish. To this mixture, 50 µl
DEAE-Dextran (Sigma-Aldrich) solution
(stock solution 10 mg ml–1) was added to give
a final concentration of 0.1 mg ml–1. The
transfection medium (5 ml per dish) was
added to each 10 cm dish and cells were incu-
bated for 1 h at 37°C, followed by washing of
cells with pre-heated 10% DMSO/PBS.
Finally, transiently transfected cells were in-
cubated at 37°C overnight in maintenance
medium. Twenty-four hours after trans-
fection cells were re-plated at a density of 2 ×
105 cells per well into 12-well plates and incu-
bated for 24 h at 37°C.
Whole-cell binding assays
Transfected COS-1 cells were washed three
times with 500 µl PBS (pre-heated at 37°C) to remove any endogenous oes-
trogen-like compounds present in the culture medium.
This was followed by a 2-hour incubation at 37°C of the transfected
cells with 1 nM radiolabelled oestradiol (3H-E2) and various unlabelled
competitors, i.e. extracts or polyphenols in DMEM without phenol red,
FCS or antibiotics. All unlabelled competitors, except for the DAE, were
dissolved in absolute ethanol (Merck) and subsequently added to the
culture medium, giving final concentrations of the phenolic compounds
and DME of 10–5 M and 1.5 µg ml–1, respectively, with the final concentra-
tion of ethanol not exceeding 0.1% (w/w). The DAE were dissolved
directly into the culture medium at a concentration of 1.5 µg ml–1. All
assays included a negative control, which was in the presence of 0.1%
ethanol, as well as positive controls, which consisted of incubations with
E2 (10
–5 M) or genistein (10–5 M).
After the 2-hour incubation, cells were immediately placed on ice and
further work was done at 4°C. Cells were washed three times with 1 ml
ice-cold 0.2% bovine serum albumin/PBS (Roche Applied Science), with
an interval of 15 min between washes to remove free ligand. Cells were
lysed with 50 µl lysis buffer (Tropix Inc.) per well, placed on a shaker for
approximately 15 min and thereafter allowed to freeze at –20°C.
Protein concentrations were used to normalize radioactivity readings
and 5 µl lysate was used for the Bradford protein assay.48
Another 50 µl of lysis buffer was then added to the remaining lysate
and this was quantitatively transferred to scintillation vials to which 3 ml
scintillation fluid (Quickszint FLOW 2; Zinsser Analytic) was added.
Radioactivity of the all assay samples was determined by recording the
counts per min for each measurement using a Beckman beta scintillation
counter (model LS 3801).
High-performance liquid chromatography analysis of Cyclopia extracts
The quantification of specific phenolic compounds in DAE and DME
was performed by reverse-phase HPLC as described by Joubert et al.6
The HPLC system (Merck Hitachi, LaChrom system, Merck, Germany)
consisted of a solvent pump (LC-7100), autosampler (L-7200), UV
detector (L-7450), diode array detector (DAD) (L-7450), interface
(D-7000) and D-7000 HPLC system manager version 4.1 for system
control and data acquisition and analysis. Solvents were degassed in-line
with a Phenomenex Degasser Model DG-4400 (Separations, South
Africa). The Phenomenex RP/C18 5µm Jour Guard column, Phenomenex
Synergy MAX-RP 80A column (C12 reverse-phase with TMS end-
capping, 4 µ m; 150 × 4.6 mm i.d.) and the Phenomenex Luna Phenyl-
hexyl column (150 mm × 4.6 mm; 3 µm) were from Separations, South
Africa. Only Int P125 was separated on the Luna Phenyl-hexyl column.
Stock solutions (c. 4 mg ml–1) dissolved in water for DAE and DMSO for
DME were prepared. They were filtered through a 25 mm 0.45-µm
Millipore Millex-HV Hydrophilic PVDF syringe filter (Microsep, South
Africa) directly into an HPLC sample vial for injection (10 µl) in duplicate,
without further dilution. Separations were carried out at 30°C with the
temperature maintained by a column oven. Tentative peak identity was
determined by means of retention time and comparison to UV spectra of
external HPLC standards. Quantification of compounds at 280 nm was
based on peak area, obtained with valley-to-valley integration, using
external standards. Quantities were expressed as a percentage of the
dried extracts. The concentration ranges of the external standards were
based on the expected levels of compounds in the dried extracts.
Data manipulation and statistical analysis
The GraphPad Prism® version 4.00 for Windows® was used for graphi-
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Table 1. Cyclopia plant material harvested and used for the preparation of dried aqueous extracts.
Species Processing Harvesting* Area harvested Date of
harvesting
C. genistoides Unfermented Gen 1G Koksrivier, Pearly Beach 15 Mar 2001
west coast type Gen 2G Koksrivier, Pearly Beach 15 Mar 2001
Gen 3G Koksrivier, Pearly Beach 15 Mar 2001
Fermented Gen 1F Koksrivier, Pearly Beach 15 Mar 2001
Gen 2F Koksrivier, Pearly Beach 15 Mar 2001
Gen 3F Koksrivier, Pearly Beach 15 Mar 2001
C. subternata Unfermented Sub 1G Waboomskraal, Outeniqua 10 Feb 1999
Sub 3G Waboomskraal, Outeniqua 10 Feb 1999
Sub 15G Du Toitskloof 01 Oct 1998
Fermented Sub 8F Waboomskraal, Outeniqua 10 Feb 1999
Sub 10F Waboomskraal, Outeniqua 17 Oct 1999
Sub 13F Waboomskraal, Outeniqua 17 Oct 1999
C. sessiliflora Unfermented Sess 2G Helderfontein, Stellenbosch 15 Feb 2001
Sess 3G Helderfontein, Stellenbosch 15 Feb 2001
Sess 4G Helderfontein, Stellenbosch 15 Feb 2001
Fermented Sess 4F Helderfontein, Stellenbosch 15 Feb 2001
Sess 6F Helderfontein, Stellenbosch 15 Feb 2001
Sess 7F Helderfontein, Stellenbosch 15 Feb 2001
C. intermedia Unfermented Int 1G Haarlem, Langkloof 10 Mar 2000
Int 2G Haarlem, Langkloof 10 Mar 2000
Int 5G Haarlem, Langkloof 10 Mar 2000
Fermented Int 2F Haarlem, Langkloof 10 Mar 2000
Int 3F Haarlem, Langkloof 10 Mar 2000
Int 4F Haarlem, Langkloof 10 Mar 2000
*The abbreviations used for the harvestings are also used for the dried aqueous extracts prepared from these collections. Although
some harvestings were conducted on the same day and on the same plantation, different numbers indicate that they involved different
plants or group of plants.
Table 2. Cyclopia plant material harvested and used for the preparation of dried
methanol extracts.
Species Harvesting* Area harvested Date of
harvesting
C. genistoides Gen P104 Koksrivier, Pearly Beach 15 Mar 2001
west coast type Gen P105 Koksrivier, Pearly Beach 28 Mar 2001
Gen P122 Koksrivier, Pearly Beach 31 Mar 2003
C. subternata Sub PY1 Bien Donne, Simondium 1 Mar 2000
Sub P111 Helderfontein, Stellenbosch 5 Mar 2001
Sub P118 Helderfontein, Stellenbosch 28 Feb 2003
C. sessiliflora Sess P69 Bien Donne, Simondium 1 Mar 2000
Sess P108 Helderfontein, Stellenbosch 14 Nov 2001
Sess P118 Helderfontein, Stellenbosch 28 Feb 2003
C. intermedia Int P111 Helderfontein, Stellenbosch 19 Feb 2001
Int PX1 Bien Donne, Simondium Jan 2000
Int P125 Helderfontein, Stellenbosch 14 Jan 2002
*The abbreviations used for the harvestings are also used for the dried methanol extracts
prepared from these collections. Although some harvestings were conducted on the same
plantation, this was done at different times.
cal representations and statistical analysis. One-way ANOVA and
Dunnett’s multiple comparisons test as post-test or paired two-tailed
t-tests were used for statistical analysis. Pearson correlations (two-tailed)
were performed and are expressed as Pearson correlation coefficient (r).
Results
Determination of extract yield and TPP content of DAE and
DME
The results of DAE and DME yields and their TPP content are
presented in Table 3. The DAE yield across all species was signifi-
cantly (P < 0.05) higher for unfermented than for fermented
plant material. For all species and unfermented plant material,
aqueous extraction gave significantly (P < 0.01) higher yields of
soluble solids than methanol extraction. A similar pattern, DAE
from unfermented plant material > DAE from fermented plant
material > DME from unfermented plant material, was ob-
served when each species was considered separately.
Within species and across all species, DAE from unfermented
plant material had a significantly (P < 0.01) higher TPP content
than the corresponding extracts from fermented plant material.
Within species, the TPP content of the DME from unfermented
material was significantly lower (P < 0.01) than that of DAE of
unfermented plant material from C. genistoides and C. subternata,
but not from C. intermedia and C. sessiliflora. However, there
was no significant difference between the DAE and DME from
unfermented plant material across all species.
Extract yield and TPP content of DAE (Pearson r = 0.34) and
DME (r = 0.28) from unfermented plant material did not corre-
late, whereas they did for fermented material (r = 0.91).
Binding to ER subtypes
All polyphenols investigated at a concentration of 10–5 M were
able significantly (P < 0.01) to displace 3H-E2 from hERβ except
for mangiferin, hesperidin, and hesperetin (Table 4). Naringenin,
luteolin and formononetin displaced more than 50%. Luteolin,
in displacing 92% of the 3H-E2 from hERβ, compared closely with
the phyto-oestrogen control, genistein, that displaced 95%
(Table 4). Eriodictyol correspondingly displaced 44% whereas
both eriocitrin and narirutin displaced 28%.
The affinity of the polyphenols for hERα was significantly less,
with eriodictyol, narirutin, eriocitrin, hesperidin, hesperetin and
mangiferin unable significantly to displace 3H-E2 from hERα
(Table 4). Although naringenin, formononetin and even luteolin
were able to compete with radiolabelled E2 for binding to both
ER receptors, the extent of their displacement of 3H-E2 from
hERα was much less (Table 4), with only luteolin displacing
more than 50% of the 3H-E2. In addition, genistein also achieved
a slightly lower displacement from hERα. Despite this, the order
of ability to displace 3H-E2 was similar for both receptor sub-
types: E2 > genistein > luteolin > naringenin > formononetin
(only for ERβ > eriodictyol > eriocitrin = narirutin).
The DAE of both fermented and unfermented Cyclopia spp.
displayed no significant binding affinity for hERα (Table 5),
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Table 3. Extract yielda and total polyphenol contentb of Cyclopia dried aqueous (DAE) and dried methanol (DME) extracts.
Species DAE from unfermented plant materialc DAE from fermented plant materialc DME from unfermented plant materiald
Harvesting Extract yield TPP content Harvesting Extract yield TPP content Harvesting Extract yield TPP content
C. genistoides Gen 1G 39.5 29.1 Gen 1F 35.5 21.8 Gen P104 13.4 22.3
Gen 2G 38.8 30.5 Gen 2F 34.3 21.8 Gen P105 13.4 22.0
Gen 3G 39.9 30.3 Gen 3F 36.8 22.3 Gen P122 18.9 25.0
Average 39.4 30.0 Average 35.5** 22.0*** Average 15.2*** 23.1**
C. subternata Sub 1G 39.8 33.2 Sub 8F 21.1 19.2 Sub P118 13.0 22.2
Sub 3G 39.7 32.4 Sub 10F 23.7 18.4 Sub P111 8.1 23.8
Sub 15G 30.6 31.9 Sub 13F 20.8 17.5 Sub PY1 14.0 23.2
Average 36.7 32.5 Average 21.9** 18.4*** Average 11.7** 22.0***
C. sessiliflora Sess 2G 31.9 29.1 Sess 4F 22.2 16.3 Sess P108 12.8 29.1
Sess 3G 33.3 29.8 Sess 6F 23.5 17.7 Sess P118 14.8 32.8
Sess 4G 32.0 30.0 Sess 7F 23.2 19.8 Sess P69 16.0 28.9
Average 32.4 29.6 Average 23.05*** 17.9*** Average 14.5*** 30.2n.s.
C. intermedia Int 1G 26.8 30.5 Int 2F 16.9 17.2 Int P111 12.8 22.9
Int 2G 25.4 29.4 Int 3F 16.3 16.1 Int PX1 15.9 25.6
Int 5G 29.1 30.6 Int 4F NDe ND Int P125 16.9 30.7
Average 27.1 30.2 Average 16.6** 16.6*** Average 15.2** 26.4n.s.
Across species Average 33.9 30.6 Average 24.2# 18.7## Average 14.2## 25.7n.s.
aYield (g) of freeze-dried extract per 100 g dried pulverized plant material.
bTotal polyphenol (TPP) content as grams gallic acid equivalents per 100 g freeze-dried extract.
cAll aqueous extracts were prepared by E.S. Richards7 from fermented and unfermented plant material as described in Materials and methods.
dAll methanol extracts were prepared from unfermented plant material as described in Materials and methods.
eN.D., no data available.
The statistical analyses were conducted using two-tailed t-tests and comparing extract yields (and TPP content) within each species (unpaired) and across all species (paired). Within each species,
the extract or TPP content was compared with the extract or TPP content of unfermented DAE (*P < 0.05, **P < 0.01, ***P < 0.001; n.s., not significant). For comparison across species, the
across-species average of fermented DAE and unfermented DME was compared with the corresponding average of unfermented DAE (#P < 0.05, ##P < 0.01; n.s., not significant).
Table 4. Summary of percentage 3H-E2 displaced from ER subtypes by the
polyphenols present in Cyclopia.
Test compounds Percentage of 3H-E2 displaceda
(10–5 M) hERα hERβ
E2
b 100**c 100**
Genisteinb 89** 95**
Luteolin 61** 92**
Naringenin 24** 70**
Formononetin 22* 58**
Eriodictyol n.s.d 44**
Eriocitrin n.s. 28**
Narirutin n.s. 28**
Hesperidin n.s. n.s.
Hesperetin n.s. n.s.
Mangiferin n.s. n.s.
aPercentage 3H-E2 displaced calculated from 10–5 M E2 set at 100% displacement and control set
as 0% displacement.
bE2 and genistein were used as positive controls.
cFor statistical analysis, one-way ANOVA was used with Dunnett’s multiple comparisons post-
test comparing binding to control (0% displacement of 3H-E2). * P < 0.05; ** P < 0.01.
dn.s., Did not significantly displace 3H-E2 from ER receptor (P > 0.05).
although the natural ligand, E2, and genistein displaced
3H-E2 to
a significant degree. The same trend was not observed when
binding to hERβ was investigated (Table 5). The DAE of unfer-
mented and fermented C. sessiliflora and C. intermedia were
unable significantly to displace 1 nM 3H-E2 from hERβ , whereas
the DAE of unfermented and fermented C. genistoides and
C. subternata were notably more consistent in binding to these
receptors. Two harvestings each from unfermented and
fermented C. genistoides DAE significantly displaced (P < 0.05)
3H-E2 from hERβ. In contrast, only two unfermented C.
subternata DAE were able to bind significantly (P < 0.05) to hERβ.
Unfermented DME of C. intermedia and C. sessiliflora showed
no significant binding affinity for either ERs (Table 5). As for the
DAE, some methanol extracts of C. genistoides and C. subternata
competed with 3H-E2 for binding to the hERβ. One C. genistoides
extract (Gen P104) displaced the highest percentage of 3H-E2
(Table 5) from both hERα and hERβ. One C. subternata extract
(Sub P118) bound significantly (P < 0.01) to both ER types.
Cyclopia genistoides DME demonstrated the highest displace-
ment of 3H-E2 and the highest consistency of binding (two out of
three harvestings) to ERβ.
HPLC analysis of DAE and DME
The Cyclopia extracts were analysed by HPLC to ascertain if the
polyphenols (luteolin, formononetin, naringenin, eriodictyol,
eriocitrin, narirutin, hesperidin, hesperetin and mangiferin)
tested, were present. Mangiferin and hesperidin were present
in all species, whether fermented or unfermented, and in all
extracts, whether DAE or DME (Tables 6, 7). Other compounds
detected were hesperetin, eriocitrin and narirutin. Hesperetin
and narirutin were present in trace amounts. Luteolin,
formononetin, naringenin and eriodictyol were not detected
by HPLC under the conditions used. The HPLC profile did,
however, show several unknown peaks, whose identification
deserves further investigation (data not shown).
Correlations
The correlation between TPP content and binding to hERα or
hERβ was investigated as phyto-oestrogens are polyphenols
(Fig. 2), but none was found for any of the extracts. Eriocitrin
and narirutin were the only known compounds present in the
extracts that were able to compete with 3H-E2 for binding to the
hERβ. Since both eriocitrin and narirutin gave the same displace-
ment (Table 4), their combined content (Fig. 3) in each extract
was correlated with the percentage 3H-E2 displaced from ERβ.
No significant correlation was found.
Discussion
Epidemiological studies indicate that the low occurrence of
certain cancers as well as less severe or no menopausal symptoms
in women from Asian countries may be due to the intake of
flavonoids, especially from soya, present in their diet.20,21 The
phenolic compounds are thought to act as weak oestrogens. In
contrast, menopausal women using traditional HRT are believed
to be more predisposed to breast cancer.23
Alternative therapies for HRT are thus being researched, as
conventional therapy does not protect menopausal women
from certain conditions such as cardiovascular disease, as was
previously thought.25 In addition, consumers are inclined to
prefer ‘natural’ alternatives, which they consider to have fewer
side-effects than synthetic drugs.19 Plant flavonoids, such as
those present in an Asian diet, are already marketed and available
to women for use as an alternative or supplement to conven-
tional HRT. These phyto-oestrogens are believed to alleviate
menopausal symptoms and to protect against oestrogen-
dependent cancers.13–15,49
Cyclopia is a possible source of phyto-oestrogens. The identifi-
cation of some examples, naringenin, luteolin, eriodictyol and
formononetin,10,11 in C. intermedia4 and anecdotal information
from a woman in the Langkloof, who drinks a herbal infusion
prepared from C. intermedia to alleviate menopausal symptoms
(pers. comm. to E. Joubert by J. Nortje, Kouga, 1996) led to this
investigation. Honeybush tea has previously been shown to be
antimutagenic and to have antioxidant properties.7,8
Several of the polyphenols present in the Cyclopia spp. were
screened for phyto-oestrogenic activity to serve as marker
compounds for future experimental studies on the phyto-
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Table 5. Summary of percentage 3H-E2 displaced from ERα and ERα receptors by
Cyclopia dried aqueous (DAE) and dried methanol (DME) extracts.
Extracts screeneda Percentage displacement of 1 nM 3H-E2b
hERα hERβ
DAE: C. genistoides
Gen 1G NBc NB
Gen 2G NB 34**d
Gen 3G NB 48**
Gen 1F NB 35*
Gen 2F NB NB
Gen 3F 1 52**
DME: C. genistoides
Gen P104 74** 70**
Gen P105 9 34**
Gen P122 12 NB
DAE: C. subternata
Sub 1G NB NB
Sub 3G NB 27*
Sub 15G 36 33*
Sub 8F NB 19
Sub 10F NB 11
Sub 13F NB NB
DME: C. subternata
Sub P118 43** 69**
Sub P111 7 5
Sub PY1 NB 6
DAE: C. sessiliflora
Sess 2G NB 2
Sess 3G 5 17
Sess 4G NB 0.2
Sess 4F 7 NB
Sess 6F 19 40
Sess 7F 16 7
DME: C. sessiliflora
Sess P108 NB NB
Sess P118 NB 2
Sess P69 NB NB
DAE: C. intermedia
Int 1G NB 2
Int 2G NB NB
Int 5G NB 28
Int 2F 2 NB
Int 3F 13 5
Int 4F 12 NB
DME: C. intermedia
Int P111 NB NB
Int PX1 NB 10
Int P125 3 3
Genistein 76** 91**
17-β-oestradiol 100** 100**
aDAE and DME were tested at a concentration of 1.5 µg ml–1. The positive controls
17-β-oestradiol and genistein were both assayed at 10–5 M (E2: 2.72 × 10–3 mg ml–1; genistein:
2.70 × 10–3 mg ml–1).
bPercentage 3H-E2 displaced calculated from 10–5 M E2 set at 100% displacement and control set
as 0% displacement.
cNB, non-binder (extracts were unable to displace 3H-E2 from respective ER).
dFor statistical analysis, one-way ANOVA was used with Dunnett’s multiple comparisons post-
test comparing binding to control (0% displacement of 3H-E2). *P < 0.05; **P < 0.01.
oestrogenic activity of honeybush. In addition, the four
commercially available honeybush tea varieties, C. genistoides,
C. subternata, C. sessiliflora and C. intermedia, were screened,
through whole-cell competitive receptor binding assays, to
ascertain which Cyclopia species contained the highest putative
phyto-oestrogenic activity and would merit further investigation.
As the plant extraction procedure is tedious and time consum-
ing, a high yield is considered an advantage and aimed for.
Additionally, the solvent used is also important for selective and
efficient extraction of flavonoids. Hesperidin, for example, is
poorly soluble in water. Similarly, extraction of aglycones is
enhanced using methanol instead of water. Fermentation
substantially reduced the DAE yield (P < 0.05), as well as its TPP
content (P < 0.01). This confirms previous studies.2,50 Methanol
was less effective than water in extracting soluble solids
(P < 0.01), but higher levels of the flavanone rutinosides,
hesperidin, narirutin and eriocitrin, were obtained. The absence
of the aglycones, luteolin, formononetin, naringenin and
eriodictyol in DAE or DME indicates either poor extraction or
low levels in the plant material. Caution should, however, be
exercised in evaluating these differences in yield and phenolic
content, especially between water and methanol extraction.
Although extracts were from the same plant species, they were
not prepared from the same harvesting nor always the same
area; these factors may contribute to variation. The plants were
not monoclonal as they were propagated from seedlings and
large genetic variation is to be expected.
Binding to the ER is the first interaction in the molecular
pathway of the oestrogen-mediated biological response.
Naringenin, formononetin, eriodictyol and luteolin, which are
known phyto-oestrogens, and narirutin, eriocitrin, hesperidin
and hesperetin, identified to be present in C. intermedia4,51 and/or
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Table 6. Phenolic content, as determined by HPLC, of the dried aqueous extracts of unfermented and fermented Cyclopia plant material.
Species Harvesting Percentage of soluble solidsa
Mangiferin Hesperidin Hesperetin Eriocitrin Narirutin Luteolin Formononetin Naringenin Eriodictyol
C. genistoides Gen 1G 10.040 ± 0.11b 1.010 ± 0.00 n.d.c 0.175 ± 0.01 n.d. n.d. n.d. n.d. n.d.
Gen 2G 8.880 ± 0.07 1.005 ± 0.01 n.d. 0.165 ± 0.01 n.d. n.d. n.d. n.d. n.d.
Gen 3G 10.04 ± 0.11 1.004 ± 0.01 n.d. 0.169 ± 0.00 n.d. n.d. n.d. n.d. n.d.
Gen 1F 3.910 ± 0.03 0.460 ± 0.00 0.01 ± 0.00 n.d. n.d. n.d. n.d. n.d. n.d.
Gen 2F 2.975 ± 0.01 0.445 ± 0.01 0.01 ± 0.00 n.d. n.d. n.d. n.d. n.d. n.d.
Gen 3F 5.845 ± 0.02 0.475 ± 0.01 n.d. n.d. n.d. n.d. n.d. n.d. n.d.
C. subternata Sub 1G 1.855 ± 0.01 0.730 ± 0.01 n.d. 0.455 ± 0.01 0.040 ± 0.00 n.d. n.d. n.d. n.d.
Sub 3G 1.025 ± 0.02 0.460 ± 0.00 n.d. 0.395 ± 0.01 0.040 ± 0.00 n.d. n.d. n.d. n.d.
Sub 15G 1.270 ± 0.01 0.390 ± 0.00 n.d. 0.405 ± 0.01 0.030 ± 0.00 n.d. n.d. n.d. n.d.
Sub 8F 0.105 ± 0.01 0.365 ± 0.01 n.d. 0.290 ± 0.00 0.040 ± 0.00 n.d. n.d. n.d. n.d.
Sub 10F 0.070 ± 0.00 0.180 ± 0.00 n.d. 0.380 ± 0.00 0.050 ± 0.00 n.d. n.d. n.d. n.d.
Sub 13F 0.090 ± 0.00 0.380 ± 0.00 n.d. 0.190 ± 0.01 0.040 ± 0.00 n.d. n.d. n.d. n.d.
C. sessiliflora Sess 1G 3.875 ± 0.09 0.515 ± 0.01 n.d. 0.285 ± 0.01 0.030 ± 0.00 n.d. n.d. n.d. n.d.
Sess 2G 4.205 ± 0.09 0.560 ± 0.00 n.d. 0.300 ± 0.00 0.030 ± 0.00 n.d. n.d. n.d. n.d.
Sess 4G 4.240 ± 0.08 0.525 ± 0.04 n.d. 0.265 ± 0.01 0.025 ± 0.01 n.d. n.d. n.d. n.d.
Sess 4F 0.180 ± 0.00 0.485 ± 0.01 n.d. 0.100 ± 0.00 0.020 ± 0.00 n.d. n.d. n.d. n.d.
Sess 7F 0.215 ± 0.01 0.400 ± 0.00 n.d. 0.155 ± 0.01 0.010 ± 0.00 n.d. n.d. n.d. n.d.
Sess 6F 0.250 ± 0.00 0.430 ± 0.00 n.d. 0.200 ± 0.00 0.025 ± 0.01 n.d. n.d. n.d. n.d.
C. intermedia Int 1G 1.815 ± 0.05 1.130 ± 0.03 0.020 ± 0.00 n.d. 0.030 ± 0.00 n.d. n.d. n.d. n.d.
Int 2G 2.085 ± 0.01 1.140 ± 0.00 0.030 ± 0.00 n.d. 0.025 ± 0.01 n.d. n.d. n.d. n.d.
Int 5G 3.300 ± 0.01 1.085 ± 0.01 0.010 ± 0.00 n.d. 0.065 ± 0.01 n.d. n.d. n.d. n.d.
Int 2F 0.200 ± 0.00 0.525 ± 0.01 0.060 ± 0.00 n.d. 0.010 ± 0.00 n.d. n.d. n.d. n.d.
Int 3F 0.240 ± 0.00 0.455 ± 0.01 0.100 ± 0.00 n.d. 0.020 ± 0.00 n.d. n.d. n.d. n.d.
Int 4F 0.245 ± 0.01 0.23 ± 0.00 0.090 ± 0.00 n.d. 0.010 ± 0.00 n.d. n.d. n.d. n.d.
aQuantities are expressed as a percentage of the extract.
bValues represent the means (% of DAE) ± s.d. of two determinations.
cNot detected.
Table 7. Phenolic content, as determined by HPLC, of the dried methanol extracts of unfermented Cyclopia plant material.
Species Harvestings Percentage of soluble solidsa
Mangiferin Hesperidin Hesperetin Eriocitrin Narirutin Luteolin Formononetin Naringenin Eriodictyol
C. genistoides Gen P104 2.77 ± 0.01b 1.22 ± 0.00 n.d.c 0.19 ± 0.00 0.35 ± 0.00 n.d. n.d. n.d. n.d.
Gen P105 2.71 ± 0.01 1.21 ± 0.00 n.d. 0.19 ± 0.01 0.35 ± 0.01 n.d. n.d. n.d. n.d.
Gen P122 2.28 ± 0.04 1.21 ± 0.01 n.d. 0.22 ± 0.00 0.31 ± 0.00 n.d. n.d. n.d. n.d.
C. subternata Sub P118 4.25 ± 0.00 1.14 ± 0.00 n.d. 0.92 ± 0.01 0.04 ± 0.00 n.d. n.d. n.d. n.d.
Sub P111 3.26 ± 0.00 0.69 ± 0.00 n.d. 0.65 ± 0.00 0.03 ± 0.01 n.d. n.d. n.d. n.d.
Sub PY1 1.705 ± 0.02 1.63 ± 0.02 n.d. 1.90 ± 0.01 0.09 ± 0.01 n.d. n.d. n.d. n.d.
C. sessiliflora Sess P108 3.69 ± 0.00 0.88 ± 0.01 n.d. 0.45 ± 0.00 0.03 ± 0.00 n.d. n.d. n.d. n.d.
Sess P118 4.28 ± 0.02 1.16 ± 0.01 n.d. 0.36 ± 0.02 0.05 ± 0.00 n.d. n.d. n.d. n.d.
Sess P69 4.61 ± 0.04 1.22 ± 0.02 n.d. 0.50 ± 0.03 0.06 ± 0.00 n.d. n.d. n.d. n.d.
C. intermedia Int P111 3.90 ± 0.02 1.28 ± 0.01 n.d. 0.21 ± 0.001 0.23 ± 0.00 n.d. n.d. n.d. n.d.
Int P X1 5.21 ± 0.01 1.53 ± 0.00 n.d. 0.21 ± 0.00 0.22 ± 0.00 n.d. n.d. n.d. n.d.
Int P125d 7.04 ± 0.06 2.34 ± 0.05 n.d. 0.63 ± 0.01 0.10 ± 0.00 n.d. n.d. n.d. n.d.
aQuantities are expressed as a percentage of the extract.
bValues represent the means (% of DME) ± s.d. of two determinations.
cNot detected.
dHarvesting was analysed on a Luna phenyl-hexyl column, which did not separate eriocitrin effectively, thus results are over-expressed.
C. subternata,5 were screened at a concentration of 10–5M for
binding to the two receptor subtypes. Mangiferin, a xanthone
glucoside, was also included in the investigation as it is present
in high concentration in all Cyclopia species.3,4,6,51
Naringenin, formononetin and luteolin bound to both ERα
and ERβ, with an order of displacement of luteolin >
naringenin > formononetin. Similar to results of the present
study, others have shown that luteolin binds to ERβ,10 as does
naringenin,10,40 which also binds weakly to ERα.40,52 Formono-
netin binds to ERβ and weakly to ERα.40 To our knowledge, bind-
ing of luteolin to hERα has not previously been investigated.
Others have shown that naringenin has a higher binding affinity
for ERβ than luteolin,10 which was not supported by our data.
However, full dose–response curves were not investigated and
therefore the results are not fully comparable to the IC50 values
determined by Han et al.10 However, we showed that naringenin
displaced more 3H-E2 from hERβ than formononetin, as did Han
et al.10 Of the other polyphenols tested, narirutin, eriocitrin, and
eriodictyol bound only to the ERβ, whereas hesperidin and its
aglycone, hesperetin, like mangiferin, did not bind to either
receptor subtype. Hesperetin has previously been shown to
have no binding affinity for the endogenously expressed ER in
MCF-7 cells.53 To our knowledge, this is the first time that
eriodictyol, narirutin, and eriocitrin have been shown to dis-
place 3H-E2 from hERβ. Eriodictyol has, however, been found to
demonstrate weak oestrogenic activity in stimulating both
MCF-7 cell proliferation and transcriptional induction of an
ERE-containing promoter.11,12
Phyto-oestrogens have been shown to have a higher affinity
for ERβ than for ERα,40 which was also demonstrated in our
study. The plant polyphenols tested, including genistein as
control, all preferentially displaced 3H-E2 from hERβ.The ERβ
may be a negative regulator of ERα activity and compounds
with selective ERβ affinity are sought, as it is believed that they
could be used for the treatment for oestrogen-dependent
cancers resulting from ERα action.54,55 The literature suggests
that ERβ activity could protect against excessive proliferation of
cancerous cells mediated by ERα.5,6,57 This phenomenon may be
the reason why phyto-oestrogens are considered an alternative
to conventional HRT as they could still protect against osteopo-
rosis and reduce cardiovascular disease, without inducing
oestrogen-dependent cancers.
As with the commercially available polyphenols, we found
that binding of Cyclopia extracts to ERβ was more significant than
to ERα. None of the DAE bound significantly to ERα and only
one out of three DME from C. genistoides and C. subternata did so.
The binding of C. genistoides extracts to ERβ exceeded that of all
other extracts, with two out of three harvestings giving signifi-
cant displacement for all extracts. Of the other Cyclopia spp., only
extracts from unfermented C. subternata (two out of three for
DAE and one out of three for DME) displayed significant bind-
ing to hERβ. Only two extracts, both DME, from C. genistoides
and C. subternata, showed significant displacement from both
receptor subtypes. Extracts from C. intermedia did not bind sig-
nificantly to either ER subtype, which was unexpected because
of the presence of isoflavones and coumestans in this genus.4
Poor extraction of aglycones due to low solubility in water, losses
during clean-up with dichloromethane for subsequent methanol
extraction, or initial low quantities of flavonoids present in the
plant material, could explain the inability of C. intermedia to
displace 3H-E2 from the two receptor subtypes.
Although the average TPP content of unfermented DAE was
significantly higher than that of both fermented DAE and
unfermented DME within species, ER binding was not corre-
lated with TPP content. This was to be expected as the Folin-
Ciocalteau assay measures only the presence and number of
hydroxyl groups, which suggests that the structural require-
ments of the polyphenols are more important in determining
oestrogenic effects than the number of these groups. Indeed,
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Fig. 2. Correlation between percentage 3H-E2 displaced from hERα () and hERβ() and percentage total polyphenol content (TPP) of (A) DAE from unfermented
plant material, (B) DAE from fermented plant material, and (C) DME from
unfermented plant material. Pearson correlations (two-tailed) were performed
using GraphPad Prism™ linear regression. All correlations are not significant.
Fig. 3. Correlation between the percentage 3H-E2 displaced from hERα by all the
extracts investigated and the amount of eriocitrin and narirutin present as
quantified by reversed phase HPLC. Pearson correlation (two-tailed) was
performed using GraphPad Prism™. Correlation is not significant.
Miksicek,58 in comparing a wide variety of polyphenols, found
that the diaryl ring structure common to all flavonoids and at
least one hydroxyl group present on each of the aromatic rings
are essential for oestrogenic activity.
Furthermore, despite the decrease in TPP content of the plant
material and subsequently of their extracts after fermentation,
both unfermented and fermented DAE of C. genistoides were
able to bind to the hERβ, suggesting that the active compound(s)
in C. genistoides is not highly susceptible to oxidation and thus is
retained to a large extent during fermentation, or that oxidative
changes did not result in changing the structure required for
binding. Fermentation did, however, have an effect on binding
of C. subternata extracts, as only unfermented DAE were able to
bind significantly to hERβ. In this case, loss of the active com-
pound(s) with oxidation is indicated, also suggesting that the
active compound(s) differs from that of C. genistoides. These find-
ings indicate that fermentation appears not to have such a
clear-cut effect on ER binding and that identification of the active
compound(s) is necessary to understand the influence of
fermentation on the binding of ER subtypes by different species.
The quantification of phenolic compounds present in DAE and
DME was carried out in an attempt to provide a chemical basis
for the observed intra- and inter-species differences. However,
the results did not explain the significant binding to the ER
subtypes by some extracts. The two major compounds,
mangiferin and hesperidin, did not bind to either receptor type.
The phyto-oestrogens, formononetin, luteolin, eriodictyol, and
naringenin, were not detected in any of the extracts (aqueous or
methanol), whereas eriocitrin and narirutin, which bound to
hERβ and could contribute to binding of some extracts, were
present only in trace amounts. It is to be expected that the
compounds that have binding affinity for the receptors would
be present in higher amounts in the active species such as
C. genistoides and C. subternata, or in extracts such as Gen 104 and
Sub P118, which competed significantly for binding to both ER
receptor subtypes. This, however, was not the case with Gen 104,
which bound significantly to both receptors, and contained sim-
ilar amounts of eriocitrin and narirutin as Int P11 bit which did
not bind to either receptor subtype. The lack of correlation
between the amount of eriocitrin and narirutin present in the
extracts examined and the displacement of E2 further confirmed
that the low levels of eriocitrin and narirutin cannot be responsi-
ble for the binding activity observed in the extracts. This matter
needs further investigation as there may be potentially novel
compounds in Cyclopia mediating the oestrogenic activity
observed.
This study indicates that not only is honeybush a source of
phyto-oestrogens, but that both aqueous and methanol extracts
preferentially bind to the hERβ. In another study conducted
with methanol extracts of the roots of Moghania philippinensis,
from the same plant family as Cyclopia, it was shown that these
extracts induced proliferation of the human breast cancer cell
line MCF-7.59 Further studies with Cyclopia are therefore desirable
to ascertain if the phyto-oestrogens present display potency in
mediating oestrogenic or possibly anti-oestrogenic effects; these
should include proliferative assays of human breast cancer cells.
These assays are essential as receptor-binding studies do not
differentiate between agonists and antagonists.
A high degree of variability in ER binding, even within the
same species, was noticeable in our results. For example, DME
from C. genistoides bound to both ER subtypes (Gen P104), only
to ERβ (Gen P105), or to neither receptor (Gen P122). All three
harvestings were from the same plantation, but were collected
on different dates and not necessarily from the same plants. One
explanation for the variability in binding ability may be that
Gen P104 was harvested during a relatively dry season in
contrast to the other two collections. Plants under stress tend to
produce more secondary metabolites, such as polyphenols, as a
protective mechanism,43 which may contribute to the higher
oestrogenicity (70% E2 displaced from hERβ) of this particular
harvesting, However, neither the TPP content nor HPLC data
support this. Another explanation may be that as the Cyclopia
industry is relatively new, there are large genotype and pheno-
type differences within one species and even within one planta-
tion. Additionally, the phyto-oestrogens previously identified to
be present in C. intermedia and C. subternata were not detected
in either the DAE or DME of these species in our study. This
variability was shown previously in terms of antimutagenicity
by van der Merwe,9 who examined the same DAE used in our
study. The variability, both in ER binding ability and content of
specific polyphenols, do however, highlight the importance of
testing for oestrogenicity of individual harvestings as no blanket
claims can at this stage be made concerning oestrogenic activity
of individual Cyclopia species. Nevertheless, our results suggest
that future studies should concentrate on investigating the
oestrogenicity of C. genistoides, which displayed the most consis-
tent phyto-oestrogenic activity. It is also important to identify
the specific compounds responsible for this activity in Cyclopia as
clearly the polyphenols thought to contribute to oestrogenicity
are not present in sufficient quantities to explain the binding
found with the extracts. In addition, at this early stage in the
industry’s history, it may be appropriate to concentrate on
producing a nutraceutical product with enhanced oestrogenic
activity from Cyclopia harvestings displaying initial high levels of
oestrogenicity than to endorse blanket statements concerning
oestrogenic activity in honeybush tea. Also required is a rapid
screening method to ensure that the plant material used to
prepare extracts displays the required activity.
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